Cholera Therapeutic Pipeline Review H2 2014

1
Cholera Pipeline Review, H2 2014 By RnRMarketResea
rch

• Browse more reports on Pharmaceuticals at
  http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
Cholera Pipeline Review, H2 2014

• Global Markets Directs, Cholera Pipeline
  Review, H2 2014', provides an overview of the
  Choleras therapeutic pipeline.
• Cholera is a disease that can kill within hours
  if left untreated. Cholera is an intestinal
  infection caused by ingestion of food or water
  that is contaminated with the bacteria. The
  disease is most common in places with poor
  sanitation, crowding, war, and famine. It affects
  both children and adults and can kill within
  hours. About 75 of people infected with
  cholera do not develop any symptoms, although the
  bacteria are present in their face for 714 days
  after infection. Up to 80 of people can be
  treated successfully through prompt
  administration of oral rehydration salts.  
• Complete report available at http//www.rnrmarketr
  esearch.com/cholera-pipeline-review-h2-2014-market
  -report.html .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
Cholera Pipeline Review, H2 2014

• This report provides comprehensive information on
  the therapeutic development for Cholera, complete
  with comparative analysis at various stages,
  therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration (RoA)
  and molecule type, along with latest updates, and
  featured news and press releases. It also reviews
  key players involved in the therapeutic
  development for Cholera and special features on
  late-stage and discontinued projects.
•  
• Note Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated disease.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
Cholera Pipeline Review, H2 2014

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Cholera.
• The report reviews key pipeline products under
  drug profile section which includes product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities.
• The report reviews key players involved in the
  therapeutics development for Cholera and enlists
  all their major and minor projects.
• The report summarizes all the dormant and
  discontinued pipeline projects.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
Cholera Pipeline Review, H2 2014

• Reasons to Buy
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies.
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage.
• Develop strategic initiatives by understanding
  the focus areas of leading companies.
• Identify and understand important and diverse
  types of therapeutics under development for
  Cholera.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
Cholera Pipeline Review, H2 2014

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441